Drawing for RIGENASIDE

USPTO serial 79373811

RIGENASIDE

Reviewed by CopyMark Law Group

Reg. 7602060Status 700Registered
Filing date
Status date
Registration date
Dec 17, 2024
Examiner
GOODWIN, KATRINA JOYE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RIGENASIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter HAUG PARTNERS, LLP745 FIFTH AVENUENEW YORK, NY 10151United States

Goods and services

ClassDescriptionStatusFirst use
003Cosmetic creams; cosmetic barrier creams; skin care preparations, other than for medical purposes; non-medicated creams for stretch marks and cellulite blemishes; cosmetic firming and slimming creams; anti-aging creams; anti-wrinkle creams; creams for skin spots, other than for medical purposes; non-medicated face and body exfoliant creams and moisturizers; massage creams and oils; beauty masks; non-medicated face and body soaps and gels; non-medicated skin care creams; soaps and intimate hygiene preparations, other than for medical purposes; cosmetic preparations for tanning the skin and sunscreen preparations; nail care preparations, other than for medical purposes; nail varnish; body cleaning preparations; deodorants and antiperspirants; make-up preparations and make-up removers; foundation and face make-up; non-medicated hair and bath preparations and treatments; hair removal and shaving preparations; non-medicated sanitary preparations being toiletries; perfumery; fragrances; essential oils and bath oils for use in aroma therapy; non-medicated oral hygiene preparationsACTIVE—
005Pharmaceutical preparations for the treatment of dermatological diseases and disorders; natural remedies for the treatment of dermatological diseases and disorders in the nature of wheat-based preparations; pharmaceutical products for gynecological use, namely, therapeutic topical creams for the treatment of gynecological diseases and disorders; medical preparations for dermatological use; pharmaceutical creams, namely, medicated lip creams, creams for dermatological use; medicinal creams for skin care; protective creams for dermatological use; topical analgesic creams; medicated creams and medical preparations for treatment of scars, skin blemishes, dermatitis and psoriasis; medicinal creams and medicated preparations for intimate hygiene; dressings, medical; sterilized dressing; disinfectants and antiseptics; bandages and plasters for skin wounds; cotton for medical purposes; sanitary preparations for medical use; medicinal mud; bath preparations for medical purposes; nutritional supplements and dietary supplements for human use; pre-filled syringes for medical purposes, namely, syringes sold filled with pharmaceutical preparations for the treatment of dermatological diseases and conditions; gauze for dressingsACTIVE—
010Syringes for medical purposes; disposable syringes; syringes for injections; vaginal syringes; hypodermic syringes; applicators for pharmaceutical preparations in the nature of syringes; apparatus for administering intravenous solutions in the nature of syringes; intravenous administration instruments for medical purposes in the nature of syringes; devices for injecting pharmaceuticals in the nature of syringes; apparatus for administering pharmaceuticals in the nature of syringes; medical apparatus and instruments for use in the removal of blemishes in subjects with signs of skin aging; therapeutic facial masks; apparatus, devices and instruments used in aesthetic medicine and dermatology treatments in the nature of medical devices to remove blemishes in subjects with signs of skin aging; apparatus, devices and instruments used in curative cosmetics in the nature of facial toning machines for cosmetic use; medical equipment, devices and instruments used in cosmetics in the nature of medical devices for nonsurgical cosmetic treatments; injectors for medical purposes; surgical implants comprised of artificial material; esthetic massage apparatus; apparatus for acne treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 13, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 23, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 23, 2025FIMPFINAL DISPOSITION PROCESSED—
Mar 17, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 28, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 17, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 17, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 11, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 11, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 15, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 28, 2024GPNXNOTIFICATION PROCESSED BY IB—
Jul 26, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jul 26, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 26, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 26, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 24, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 1, 2024GPNXNOTIFICATION PROCESSED BY IB—
Jun 14, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 13, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 12, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 11, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
May 23, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 23, 2024XAECEXAMINER'S AMENDMENT ENTERED—
May 23, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 23, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
May 23, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
May 23, 2024GRMLCORRESPONDENCE E-MAILED—
May 23, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 23, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2024RFNTREFUSAL PROCESSED BY IB—
Jan 25, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 25, 2024RFRRREFUSAL PROCESSED BY MPU—
Jan 10, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 9, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2024DOCKASSIGNED TO EXAMINER—
Jul 20, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 16, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 13, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance